Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial
PaperCitations, authors & open-access status
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 424 citations, 2013 year and closed oa status.
424
Citations
2013
Year
closed
OA Status